Evidence map›Paper›PMID 26853136›Full record

ArticleExperimental neurology2016

Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.

Dario I Carrasco, Ben A Bahr, Kevin L Seburn, Martin J Pinter

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Motor function recovery: deciphering a regenerative niche at the neuromuscular synapse.Biological reviews of the Cambridge Philosophical Society · 2021
    Review
  10. Review
  11. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in theThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  12. Review
  13. Review
  14. Review
  15. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.International journal of molecular sciences · 2017
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Dario I CarrascoDepartment of Physiology, Emory University, Atlanta, GA, USA.
Ben A BahrBiotechnology Research and Training Center, University of North Carolina at Pembroke, Pembroke, NC, USA.
Kevin L SeburnThe Jackson Laboratory, Bar Harbor, ME, USA.
Martin J PinterDepartment of Physiology, Emory University, Atlanta, GA, USA. Electronic address: mpinter@emory.edu.
Emory University · USJackson Laboratory · USUniversity of North Carolina at Pembroke · US

Funding

MOTOR NEURON DISEASE-NEUROPHYSIOLOGY AND PATHOLOGYR01NS031621 · NINDS · EMORY UNIVERSITY · PI PINTER, MARTIN J · 1993 to 2006
$1.8M
FEI Transmission Electron Microscope with Tomography CapabilityS10RR025679 · NCRR · EMORY UNIVERSITY · PI SPEARMAN, PAUL W. · 2009 to 2009
$500k
Wild-type nerve grafting promotes reinnervation of SOD1 muscleR21NS079948 · NINDS · EMORY UNIVERSITY · PI PINTER, MARTIN J · 2013 to 2014
$427k
NCRR NIH HHS S10 RR025679NCRR NIH HHS S10RR025679NINDS NIH HHS NS074231NINDS NIH HHS R01 NS031621NINDS NIH HHS R21 NS079948
6 · The paper itself

Abstract

In several animal models of motor neuron disease, degeneration begins in the periphery. Clarifying the possible role of Schwann cells remains a priority. We recently showed that terminal Schwann cells (TSCs) exhibit abnormalities in postnatal mice that express mutations of the SOD1 enzyme found in inherited human motor neuron disease. TSC abnormalities appeared before disease-related denervation commenced and the extent of TSC abnormality at P30 correlated with the extent of subsequent denervation. Denervated neuromuscular junctions (NMJs) were also observed that lacked any labeling for TSCs. This suggested that SOD1 TSCs may respond differently than wildtype TSCs to denervation which remain at denervated NMJs for several months. In the present study, the response of SOD1 TSCs to experimental denervation was examined. At P30 and P60, SC-specific S100 labeling was quickly lost from SOD1 NMJs and from preterminal regions. Evidence indicates that this loss eventually becomes complete at most SOD1 NMJs before reinnervation occurs. The loss of labeling was not specific for S100 and did not depend on loss of activity. Although some post-denervation labeling loss occurred at wildtype NMJs, this loss was never complete. Soon after denervation, large cells appeared near SOD1 NMJ bands which colabeled for SC markers as well as for activated caspase-3 suggesting that distal SOD1 SCs may experience cell death following denervation. Denervated SOD1 NMJs viewed 7 days after denervation with the electron microscope confirmed the absence of TSCs overlying endplates. These observations demonstrate that SOD1 TSCs and distal SCs respond abnormally to denervation. This behavior can be expected to hinder reinnervation and raises further questions concerning the ability of SOD1 TSCs to support normal functioning of motor terminals.

Indexed as

Disease Models, AnimalAge FactorsAnimalsAntigens, DifferentiationGene Expression RegulationHumansMiceMice, Inbred C57BLMice, TransgenicMotor Neuron DiseaseMuscle DenervationMutationNerve RegenerationNeuromuscular JunctionReceptor, Nerve Growth FactorReceptors, CholinergicAntigens, Differentiationmonocyte-macrophage differentiation antigenReceptor, Nerve Growth FactorReceptors, CholinergicS100 ProteinsSOD1 G93A proteinSuperoxide DismutaseDenervation cell deathMotor neuron diseaseMotor terminalNeurodegenerationSchwann cell

Identifiers

PMID26853136
PMCPMC4788963
OpenAlexW2292919276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.